With Covid-19 resurging in China, China JoJo Drugstore, Inc. (NASDAQ: CJJD) may be well-positioned to capitalize on this unfortunate situation thanks to its status as a leader in the Chinese pharmaceutical market. Since demand for medications would soar as Covid cases increase, CJJD’s revenues could be poised to soar. Meanwhile, CJJD is expected to post its 2023...
Fairly obvious impulse nearing completion on the bearish side. Wave 5 is awaited.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Confirmation level, where relevant, is a pink dotted, finite line. Fibonacci goals, it is...
looking at the technicals. This is on a (possible short-term) upswing. Its been up already so i took that into consideration. Not the normal 100% "TO DA MOON" projection, but a realisitic 10%-30% is possible.
Hello,
What is CJJD?
China Jo-Jo Drugstores, Inc., through its contractually controlled affiliates, operates a retail pharmacy chain in China offering both western and traditional Chinese medicine. Its contractually controlled affiliates include Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd., Hangzhou Jiuzhou Clinic of Integrated Traditional and Western...
Contextual immersion trading strategy idea.
China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China.
The demand for shares of the company looks higher than the supply.
These and other conditions can cause a rise in the share price in...
Contextual immersion trading strategy idea.
China Jo-Jo Drugstores, Inc., together with its subsidiaries, operates as a retailer and distributor of pharmaceutical and other healthcare products in the People's Republic of China.
The demand for shares of the company looks higher than the supply.
These and other conditions can cause a rise in the share price in...
Chinese pharma play:
- Move from 1.00 (May 24, '19) to recent $2.24 top (Jan 27, '20) and back to $1.73 today marks an approximate 50% retrace over the last 9 months
- Currently in the heat of the Coronavirus battle; will likely show a bump in it's topline next quarterly report (July?)
- Currently faces resistance at the baseline of the BB bands and 50MA which...
